According to Celsis, ReACT assays use proprietary selections of ribosomal RNA sequences to confirm or to rule out the presence of Gram-negative organisms, Staphylococcus aureus, yeast and mold, and can be customized for facility-specific or wild strain organisms.
Celsis said that its customers will be able to use Celsis ReACT following the primary Celsis AKuScreen assay, which definitively detects the presence or absence of microbial organisms in 18-24 hours instead of the typical three to five days for microbial limits testing.
Jay LeCoque, CEO of Celsis, said: “We developed Celsis ReACT for our customers who have asked for a way to quickly and easily determine if they have an objectionable organism, so they can minimize the financial impact to their operations and bottom line.”